Format

Send to

Choose Destination
J Pediatric Infect Dis Soc. 2018 May 15;7(2):e43-e46. doi: 10.1093/jpids/piy004.

Effect of the Procalcitonin Assay on Antibiotic Use in Critically Ill Children.

Author information

1
Division of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Washington, DC.
2
Division of Critical Care Medicine, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Ohio.
3
Division of Critical Care Medicine, Department of Anesthesiology and Critical Care, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine.
4
Division of General Pediatrics, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine.
5
McCourt School of Public Policy, Georgetown University, Washington, DC.
6
Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia.
7
Department of Nursing, Respiratory Care and Neurodiagnostic Services, Children's Hospital of Philadelphia, Pennsylvania.

Abstract

We retrospectively studied the effect of introducing procalcitonin into clinical practice on antibiotic use within a large academic pediatric intensive care unit. In the absence of a standardized algorithm, availability of the procalcitonin assay did not reduce the frequency of antibiotic initiations or the continuation of antibiotics for greater than 72 hours.

PMID:
29529219
DOI:
10.1093/jpids/piy004
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center